Limited number of CVS Pharmacy locations will offer vaccinations in 11 states
WOONSOCKET, R.I. — Starting Thursday, February 11, CVS Health (NYSE: CVS) will begin to offer COVID-19 vaccinations to eligible populations at a limited number of CVS Pharmacy locations across 11 states. Supply for the initial rollout, which is sourced directly from the federal government through the pharmacy partnership program, will be approximately 250,000 total doses. As more supply becomes available the company will expand to additional states while increasing the number of stores offering vaccinations.
“Our presence in communities across the country makes us an ideal partner for administering vaccines in a safe, convenient, and familiar manner,” said Karen S. Lynch, President and Chief Executive Officer, CVS Health. “This is particularly true for underserved communities, which have been a focus for us throughout the pandemic.”
There are nearly 10,000 CVS Pharmacy locations nationwide, with almost half located in communities ranked high or very high in the Centers for Disease Control and Prevention Social Vulnerability Index. More than 90,000 health care professionals including pharmacists, licensed pharmacy technicians, and nurses will participate in the vaccination effort, giving CVS Pharmacy the capacity to administer 20 – 25 million shots per month.
State-specific details (eligibility will be confirmed and communicated by states in advance of the rollout):
|100||California Department of Public Health|
|12||Connecticut COVID-19 Response|
|7||Hawai‘i State Department of Health|
|18||Maryland Department of Health covidLINK|
|Massachusetts||21,600||18||Massachusetts' COVID-19 vaccination phases|
|New Jersey||19,900||27||New Jersey Department of Health|
||20,600||32||New York State Department of Health|
|Rhode Island||3,400||4||Rhode Island Department of Health|
|South Carolina||15,300||17||South Carolina Department of Health and Environmental Control|
|Texas||38,000||70||Texas Department of State Heath Services|
|Virginia||26,000||28||Virginia Department of Health|
CVS Health is also working directly with Indiana (utilizing two CVS Pharmacy locations) and Ohio (19) to provide in-store vaccinations to eligible populations using state allocations. Other states may choose the same option, which is separate from the federal pharmacy partnership program but can run concurrently.
Vaccines in a retail setting will be offered on an appointment-only basis via CVS.com or through the CVS Pharmacy app, and those without online access can contact customer service: 1-800-746-7287. For CVS Pharmacy locations that will begin to offer COVID-19 vaccinations on February 11, appointments will become available for booking as early as February 9 as stores receive shipment.
Long-term care vaccination effort remains on schedule
CVS Health has administered the first round of COVID-19 vaccine doses to nearly 8,000 skilled nursing facilities, and second doses are more than 60 percent complete. First doses at all long-term care facilities that selected CVS Health to provide COVID-19 vaccinations – more than 40,000 in total – will be complete by mid-February.
Multimedia assets, including b-roll and still photography from long-term care facility and in-store COVID-19 vaccinations, are available here. More information on steps CVS Health has taken to address the pandemic is available at the company's frequently updated COVID-19 resource center.
About CVS Health
CVS Health is a different kind of health care company. We are a diversified health services company with nearly 300,000 employees united around a common purpose of helping people on their path to better health. In an increasingly connected and digital world, we are meeting people wherever they are and changing health care to meet their needs. Built on a foundation of unmatched community presence, our diversified model engages one in three Americans each year. From our innovative new services at HealthHUB® locations, to transformative programs that help manage chronic conditions, we are making health care more accessible, more affordable and simply better. Learn more about how we're transforming health at www.cvshealth.com.
Cautionary statement concerning forward-looking statements
The Private Securities Litigation Reform Act of 1995 provides a safe harbor for forward-looking statements made by or on behalf of CVS Health Corporation. By their nature, all forward-looking statements are not guarantees of future performance or results and are subject to risks and uncertainties that are difficult to predict and/or quantify. Actual results may differ materially from those contemplated by the forward-looking statements due to risks and uncertainties described in our Securities and Exchange Commission (“SEC”) filings, including those set forth in the Risk Factors section and under the heading “Cautionary Statement Concerning Forward Looking Statements” in our most recently filed Annual Report on Form 10-K and our Quarterly Report on Form 10-Q for the quarterly period ended September 30, 2020. You are cautioned not to place undue reliance on CVS Health’s forward looking statements. CVS Health’s forward-looking statements are and will be based upon management’s then-current views and assumptions regarding future events and operating performance, and are applicable only as of the dates of such statements. CVS Health does not assume any duty to update or revise forward-looking statements, whether as a result of new information, future events, uncertainties or otherwise.